On April 2, 2019, the State of Connecticut General Assembly issued public act 19-159. The act concerns mental health and substance use disorder benefits. This bill requires certain health insurance policies that cover prescription drugs to also cover drugs prescribed to treat substance use disorder, provided the treatment complies with approved federal Food and Drug Administration (FDA) indications. If the policy includes multiple cost sharing tiers, the insurer must place such drugs in the lowest tier . . .